Ferring Pharmaceuticals and PharmaBiome have entered into a research and development collaboration to advance new microbiome-based biotherapeutics in the field of gastroenterology. The deal provides Ferring with exclusive rights to develop, manufacture and commercialize next generation microbiome-based therapeutics resulting from the collaboration. PharmaBiome has developed a technology platform to select bacterial strains for the design of bacterial consortia as live biotherapeutics with ...